Zydus launches Topiramate Extended-Release Capsules
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Acquisitions have the potential to add at least $1 billion in sales by 2028
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
To create leading company developing medicines targeting metalloenzymes
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Having a healthy gut is key as it permits the body to build a stronger immune system
Cipla and Ethris partner for the development of mRNA-based therapies
Subscribe To Our Newsletter & Stay Updated